1. Home
  2. BGT vs TRDA Comparison

BGT vs TRDA Comparison

Compare BGT & TRDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BlackRock Floating Rate Income Trust

BGT

BlackRock Floating Rate Income Trust

HOLD

Current Price

$10.76

Market Cap

318.8M

Sector

Finance

ML Signal

HOLD

TRDA

Entrada Therapeutics Inc.

HOLD

Current Price

$6.55

Market Cap

275.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BGT
TRDA
Founded
N/A
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
318.8M
275.3M
IPO Year
2004
2021

Fundamental Metrics

Financial Performance
Metric
BGT
TRDA
Price
$10.76
$6.55
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$21.00
AVG Volume (30 Days)
119.9K
269.4K
Earning Date
01-01-0001
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$25,421,000.00
Revenue This Year
N/A
$39.97
Revenue Next Year
N/A
$50.80
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.22
$5.08
52 Week High
$12.28
$16.45

Technical Indicators

Market Signals
Indicator
BGT
TRDA
Relative Strength Index (RSI) 40.04 42.12
Support Level $10.61 $5.71
Resistance Level $10.83 $7.89
Average True Range (ATR) 0.08 0.43
MACD -0.04 -0.06
Stochastic Oscillator 18.09 18.17

Price Performance

Historical Comparison
BGT
TRDA

About BGT BlackRock Floating Rate Income Trust

Blackrock Floating Rate Income Trust is a diversified closed-end management investment company. Its investment objective is to provide a high level of current income. The company, as a secondary objective, also focuses on preservation of capital to the extent consistent with its primary objective of high current income. The Trust seeks to achieve its investment objectives by investing in worl-wide portfolio of floating rate securities, including investing a substantial amount in U.S. and non-U.S. senior secured floating rate loans (Senior Loans), made to corporate and other business entities.

About TRDA Entrada Therapeutics Inc.

Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company. It aims to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient intracellular delivery into a variety of organs and tissues, resulting in an improved therapeutic index and protein-based programs for the potential treatment of neuromuscular and ocular diseases, among others. Its oligonucleotide programs are in development for the potential treatment of people living with Duchenne, which are exon 44, 45, 50, and 51 skipping amenable. It has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1.

Share on Social Networks: